Loading clinical trials...
Loading clinical trials...
In this prospective, phase 2b, multicenter, randomized, double-masked, vehicle-controlled, parallel-arm study, approximately 880 subjects with moderate to severe dry eye disease (DED) will be randomly...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Telios Pharma, Inc.
NCT07656688 · Dry Eye Disease (DED)
NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more
NCT07463950 · Dry Eye Disease (DED)
NCT07412860 · Dry Eye Syndromes, Dry Eye Disease (DED)
NCT07363824 · Dry Eye Disease, Iron
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Global Research Management
Glendale, California
Nvision - La Mesa
La Mesa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions